The highest frequency of homozygous deletions of p16INK4a or p15INK4b occurs in ALL, while they are heterozygously deleted in chronic lymphocytic leukemia (CLL) (114, 119–121). Here, CDKN2A is linked to B-cell chronic lymphocytic leukemia.